For instance, Imoto et al. reported significantly higher levels of VEGF receptor expression in adenocarcinoma compared to SCC [33], whereas Shimanuki et al. identified significantly lower serum VEGF levels in patients with adenocarcinoma than in those with SCC [30]. This evidence concerns the gene VEGFA and adenocarcinoma.